CERENOME, INC. Cost of Revenue
CERENOME, INC. (CNSY) reported Cost of Revenue of $1.15 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2019-03-29
- CERENOME, INC. cost of goods and services sold for fiscal 2018 was $1.15M, a 12.90% decline from fiscal 2017.
- CERENOME, INC. cost of goods and services sold for fiscal 2017 was $1.32M.
| Period end | Cost of Goods and Services Sold 12 month |
|---|---|
| 2018-12-31 | $1.15M 10-K · filed 2019-03-29 |
| 2017-12-31 | $1.32M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |